Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000295420

Medchemexpress LLC Enozertinib hemihydrate | 2489185-38-6 | 100.0% | 669.77 | C35H42F2N8O3·1/2H2O | 10 MG
SDP

Catalog No. 5000295420
Encompass_Preferred

Enozertinib hemihydrate is a small-molecule, brain-penetrant inhibitor of EGFR and HER2 supplied as a hemihydrate for research use. It is orally bioavailable and exhibits antineoplastic activity against EGFR-altered tumors, including exon 20 insertions; intended for laboratory research and not for human use.

  • Hemihydrate form for consistent handling and stability.
  • High purity suitable for biochemical and cellular assays.
  • Brain-penetrant and orally bioavailable properties.
  • Targets EGFR and HER2 alterations, including exon 20 insertions.
  • Supplied in small-mass packs for preclinical research.

Catalog No. 50-002-95420 Supplier Medchemexpress LLC Supplier No. HY172429A10MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Enozertinib hemihydrate is a small-molecule, brain-penetrant inhibitor of EGFR and HER2 supplied as a hemihydrate for research use. It is orally bioavailable and exhibits antineoplastic activity against EGFR-altered tumors, including exon 20 insertions; intended for laboratory research and not for human use.

  • Hemihydrate form for consistent handling and stability.
  • High purity suitable for biochemical and cellular assays.
  • Brain-penetrant and orally bioavailable properties.
  • Targets EGFR and HER2 alterations, including exon 20 insertions.
  • Supplied in small-mass packs for preclinical research.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.